Published in

Springer, Investigational New Drugs, 4(38), p. 1108-1116, 2019

DOI: 10.1007/s10637-019-00864-7

Links

Tools

Export citation

Search in Google Scholar

Phase I study of the mTOR inhibitor everolimus in combination with the histone deacetylase inhibitor panobinostat in patients with advanced clear cell renal cell carcinoma

Journal article published in 2019 by Anthony Wood, Saby George ORCID, Nabil Adra, Sreenivasulu Chintala, Nur Damayanti, Roberto Pili ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO